# Study of Cicletanine for Pulmonary Arterial Hypertension (PAH)

> **NCT00832507** · PHASE2 · TERMINATED · sponsor: **Gilead Sciences** · enrollment: 162 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** Cicletanine
- **DRUG:** Cicletanine Placebo

## Key facts

- **NCT ID:** NCT00832507
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-01
- **Primary completion:** 2011-10
- **Final completion:** 2012-03
- **Target enrollment:** 162 (ACTUAL)
- **Last updated:** 2014-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00832507

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00832507, "Study of Cicletanine for Pulmonary Arterial Hypertension (PAH)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00832507. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*